So I dunno when $MRK will release the numeric gefapixant data but we know 15mg failed and 45mg hit which likely implies a large reduction in efficacy vs ph2. It seems likely to me that Merck’s ph3 data will mirror $BLU ph2 data showing impact in only ~1/2 of most severe coughers.